Practice
Shuang Zhao is a partner in Shearman & Sterling’s Hong Kong office. Her practice focuses on capital markets matters and she has worked on a variety of equity, equity-linked and debt offerings.  Transactions in which she has been involved include SEC-registered offerings, Rule 144A/Regulation S offerings and listings in the United States and Hong Kong.  Ms. Zhao regularly advises public companies on corporate governance and regulatory compliance matters, including issues arising under the Sarbanes-Oxley Act. 

Ms. Zhao has been named as a leading individual for debt and equity capital markets in Hong Kong by IFLR1000 Guide to the World’s Leading Financial Law Firms.

• GDC Technology Limited in its proposed initial public offering and NASDAQ listing
• China National Petroleum Corporation, China Petroleum Finance Company Limited, CNPC Finance (HK) Limited and CNPC Golden Autumn Limited in connection with the offering of CNY2.5 billion 2.550% Guaranteed Bonds due 2013 and CNY500 million 2.950% Guaranteed Bonds due 2014 guaranteed by CNPC Finance (HK) Limited. BOCI, HSBC, Deutsche Bank and ICBC are the Joint Lead Managers
• Merrill Lynch, Pierce, Fenner & Smith Incorporated, as the initial purchaser, in the private placement by China Medical Technologies, Inc. of US$150 million aggregate principal amount of 6.25% Convertible Senior Notes due 2016, convertible into American Depositary Shares, including a concurrent capped call transaction
• Jefferies & Company, Inc. as the Sole Bookrunner and Underwriter in connection with the follow-on offering of ordinary shares by China Cord Blood Corporation. China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator in China with multiple licenses
• Goldman Sachs, Credit Suisse and Barclays Capital, in connection with Trina Solar Limited, a leading solar energy company, in its US$184 million follow-on offering and listing on the New York Stock Exchange of 7,900,000 ADSs
• Goldman Sachs and Credit Suisse, in connection with Trina Solar Limited’s US$148.8 million follow-on offering and listing on the New York Stock Exchange of ADSs
• The underwriters, in connection with Jinko Solar, a leading solar energy company, in its S64.2 million initial public offering and listing on the New York Stock Exchange
• Suntech Power Holdings Co., Ltd., a leading solar energy company in the world, in connection with its US$287.5 million follow-on offering and listing on the New York Stock Exchange of 4,000,000 ADSs
• China Medical Technologies, Inc. in its SEC-registered concurrent offerings of 4.00% Convertible Senior Notes due 2013 in the aggregate principal amount of $276 million and up to 4,700,000 ADSs
• Credit Suisse, ABN AMRO and Deutsche Bank, in connection with Trina Solar Limited’s SEC-registered concurrent offerings of 4.00% Convertible Senior Notes due 2013 in the aggregate principal amount of $138 million and up to 4,000,000 ADSs
• Suntech Power Holdings Co., Ltd. in connection with its Rule 144A offering of US$575 million convertible note
• China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, in connection with its US$384 million initial public offering and listing on the New York Stock Exchange of 23,718,750 ADSs
• Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market, in connection with its US$260.5 million initial public offering on the New York Stock Exchange of 15,625,000 ADSs
• Suntech Power Holdings Co., Ltd. in connection with its Rule 144A offering of US$500 million convertible notes
• China Medical Technologies, Inc. in its Rule 144A offering of US$125 million convertible notes
• Suntech Power Holdings Co., Ltd. in its initial public offering on the New York Stock Exchange
• Vimicro International Corporation, a leading fabless semi-conductor design house in its NASDAQ IPO
• Ctrip.com International Ltd. in a secondary public offering of ADSs
• Deutsche Bank as new depositary for a F-6 registration of level-one ADSs for New World Development Company Limited
• Citigroup in CSMC Technologies Corporation’s Initial Public Offering on the Hong Kong Stock Exchange
• Goldman Sachs in High Tech Computer’s offering of 6,550,000 Global Depositary Receipts
• Lehman Brothers in CMC Magnetics Corporation’s offering of US$168 Million Convertible Bonds
• ABN AMRO in Hon Hai Precision Industry Co., Ltd.’s offering of US$450 Million Zero Coupon Convertible Bonds due 2008
• UBS Warburg in Far Eastern International Bank’s offering of US$100 Million Zero Coupon Convertible Bonds due 2008
• Taishin Financial Holdings Co. Ltd. in its offering of US$200 Million Zero Coupon Convertible Bonds due 2008
• JP Morgan in CMC Magnetics Corporation’s offering of US$135 Million Zero Coupon Convertible Bonds due 2008
• UBS Warburg in High Tech Computer Corp.’s offering of US$60 Million Zero Coupon Convertible Bonds due 2008
• JP Morgan in Chinatrust Financial Holdings Company, Ltd.’s offering of US$400 Million Zero Coupon Convertible Bonds due 2008
• Salomon Smith Barney in Acer Communication & Multimedia Inc.’s offering of US$200 Million Zero Coupon Convertible Bonds due 2006
• Goldman Sachs in Hon Hai Precision Industry Co., Ltd.’s offering of US$345 Million SIZeS due 2005

• Cordlife Group Limited, a company limited by shares incorporated in Singapore and listed on the Singapore Exchange Securities Trading Limited, in its acquisition of 7,314,015 shares of China Cord Blood Corporation, a Cayman Islands corporation listed on the New York Stock Exchange, for a cash consideration of approximately US$20.8 million
• Simcere Pharmaceutical Group in joint venture with Merck & Co., Inc.
• Trony Solar Holdings Limited, a leading thin film solar energy company in China, in connection with its US$50 million pre-IPO preferred stock financing transactions involving private equity investors
• An existing shareholder of Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market, in connection with its private sale of its ordinary shares to Trust Bride Partners
• Suntech Power Holdings Co., Ltd. in its acquisition of MSK Corporation, one of Japan's largest PV manufacturers. The acquisition took place in two-steps with a total consideration of up to US$300 million. This transaction marks the first cross border acquisition by Suntech Power and is one of the largest cross-border acquisitions by a non-state owned Chinese company to date
• China Medical Technologies, Inc. in its pre-IPO financing, acquisition, restructuring and NASDAQ IPO 
• DBS in a private equity transaction
• A PRC retailer in a restructuring and subsequent M&A transaction